CXCR4-mediated T cell apoptosis in human immunodeficiency virus infection

Journal of General Virology

Volumn 85, Issue 6, 2004, Pages 1471-1478

  Decrion, Anne Zélie ^a   Varin, Audrey ^a   Estavoyer, Jean Marie ^a   Herbein, Georges ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CXCR4;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; APOPTOSIS; ARTICLE; CELL CONTACT; CELL ISOLATION; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MACROPHAGE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BLOCKING; SYMPTOMATOLOGY; SYNCYTIUM; T LYMPHOCYTE; VIRUS ENVELOPE; AGED; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; AGED; APOPTOSIS; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MIDDLE AGED; RECEPTORS, CXCR4; T-LYMPHOCYTES;

EID: 2942661875     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.79933-0     Document Type: Article

References (51)

1. Alexander-Miller, M. A., Derby, M. A., Sarin, A., Henkart, P. A. & Berzofsky, J. A. (1998). Supraoptimal peptide-major histocompatibility complex causes a decrease in bcl-2 levels and allows tumor necrosis factor alpha receptor II-mediated apoptosis of cytotoxic T lymphocytes. J Exp Med 188, 1391-1399.
2. Algeciras-Schimnich, A., Vlahakis, S. R., Villasis- Keever, A., Gomez, T., Heppelmann, C. J., Bou, G. & Paya, C. V. (2002). CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells. AIDS 16, 1467-1478.
3. Ameisen, J. C. & Capron, A. (1991). Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today 12, 102-105.
4. Ara, T., Itoi, M., Kawabata, K., Egawa, T., Tokoyoda, K., Sugiyama, T., Fujii, N., Amagai, T. & Nagasawa, T. (2003). A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo. J Immunol 170, 4649-4655.
5. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med 185, 55-64.
6. Badley, A. D., Parato, K., Cameron, D. W. & 7 other authors (1999). Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ 6, 420-432.
7. Banda, N. K., Bernier, J., Kurahara, D. K., Kurrle, R., Haigwood, N., Sekaly, R. P. & Finkel, T. H. (1992). Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176, 1099-1106.
8. Baribaud, F., Edwards, T. G., Sharron, M. & 7 other authors (2001). Antigenically distinct conformations of CXCR4. J Virol 75, 8957-8967.
9. Berger, E. A., Murphy, P. M. & Farber, J. M. (1999). Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17, 657-700.
10. + T cells. Proc Natl Acad Sci U S A 95, 12556-12561.
11. Blanco, J., Barretina, J., Henson, G., Bridger, G., De Clercq, E., Clotet, B. & Este, J. A. (2000). The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosis. Antimicrob Agents Chemother 44, 51-56.
12. + T cell death during human immunodeficiency virus infection in vitro. Virology 285, 356-365.
13. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J. & Springer, T. A. (1996). The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833.
14. + patients. Clin Exp Immunol 120, 101-106.
15. Castro, B. A., Weiss, C. D., Wiviott, L. D. & Levy, J. A. (1988). Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells. J Clin Microbiol 26, 2371-2376.
16. Davis, C. B., Dikic, I., Unutmaz, D., Hill, C. M., Arthos, J., Siani, M. A., Thompson, D. A., Schlessinger, J. & Littman, D. R. (1997). Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 186, 1793-1798.
17. de Clercq, E. & Schols, D. (2001). Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists. Antivir Chem Chemother 12, 19-31.
18. de Oliveira Pinto, L. M., Garcia, S., Lecoeur, H., Rapp, C. & Gougeon, M. L. (2002a). Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3. Blood 99, 1666-1675.
19. de Oliveira Pinto, L. M., Lecoeur, H., Ledru, E., Rapp, C., Patey, O. & Gougeon, M. L. (2002b). Lack of control of T cell apoptosis under HAART. Influence of therapy regimen in vivo and in vitro. AIDS 16, 329-339.
20. Donzella, G. A., Schols, D., Lin, S. W. & 8 other authors (1998). AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med 4, 72-77.
21. Doranz, B. J., Grovit-Ferbas, K., Sharron, M. P., Mao, S. H., Goetz, M. B., Daar, E. S., Doms, R. W. & O'Brien, W. A. (1997). A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J Exp Med 186, 1395-1400.
22. Dyrhol-Riise, A. M., Ohlsson, M., Skarstein, K., Nygaard, S. J., Olofsson, J., Jonsson, R. & Asjo, B. (2001). T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy. Clin Immunol 101, 180-191.
23. Fauci, A. S. (1996). Host factors and the pathogenesis of HIV-induced disease. Nature 384, 529-534.
24. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
25. Finkel, T. H., Tudor-Williams, G., Banda, N. K., Cotton, M. F., Curiel, T., Monks, C., Baba, T. W., Ruprecht, R. M. & Kupfer, A. (1995). Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med 1, 129-134.
26. + T cells by a Fas-independent mechanism. J Exp Med 187, 1113-1122.
27. Giorgi, J. V., Hultin, L. E., McKeating, J. A. & 9 other authors (1999). Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179, 859-870.
28. Glushakova, S., Grivel, J. C., Fitzgerald, W., Sylwester, A., Zimmerberg, J. & Margolis, L. B. (1998). Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency. Nat Med 4, 346-349.
29. Hatse, S., Princen, K., Bridger, G., De Clercq, E. & Schols, D. (2002). Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 527, 255-262.
30. + T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 395, 189-194.
31. Herbein, G., Van Lint, C., Lovett, J. L. & Verdin, E. (1998b). Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J Virol 72, 660-670.
32. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. & Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
33. Koot, M., Vos, A. H., Keet, R. P., de Goede, R. E., Dercksen, M. W., Terpstra, F. G., Coutinho, R. A., Miedema, F. & Tersmette, M. (1992). HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 6, 49-54.
34. Labrosse, B., Brelot, A., Heveker, N., Sol, N., Schols, D., de Clercq, E. & Alizon, M. (1998). Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100. J Virol 72, 6381-6388.
35. Lapham, C. K., Romantseva, T., Petricoin, E., King, L. R., Manischewitz, J., Zaitseva, M. B. & Golding, H. (2002). CXCR4 heterogeneity in primary cells: possible role of ubiquitination. J Leukoc Biol 72, 1206-1214.
36. Loetscher, M., Geiser, T., O'Reilly, T., Zwahlen, R., Baggiolini, M. & Moser, B. (1994). Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J Biol Chem 269, 232-237.
37. Matthys, P., Hatse, S., Vermeire, K., Wuyts, A., Bridger, G., Henson, G. W., de Clercq, E., Billiau, A. & Schols, D. (2001). AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-γ receptor-deficient mice. J Immunol 167, 4686-4692.
38. + T cells. Immunity 15, 871-882.
39. Nagasawa, T., Kikutani, H. & Kishimoto, T. (1994). Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci U S A 91, 2305-2309.
40. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N., Kikutani, H. & Kishimoto, T. (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635-638.
41. + T cell activation. J Immunol 164, 5010-5014.
42. Olsson, J., Poles, M., Spetz, A. L., Elliott, J., Hultin, L., Giorgi, J., Andersson, J. & Anton, P. (2000). Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. J Infect Dis 182, 1625-1635.
43. + T cell apoptosis: a possible mechanism of bystander cell death in HIV infection. J Immunol 158, 2456-2463.
44. Roggero, R., Robert-Hebmann, V., Harrington, S., Roland, J., Vergne, L., Jaleco, S., Devaux, C. & Biard-Piechaczyk, M. (2001). Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling. J Virol 75, 7637-7650.
45. Saag, M. S., Holodniy, M., Kuritzkes, D. R. & 7 other authors (1996). HIV viral load markers in clinical practice. Nat Med 2, 625-629.
46. Tateyama, M., Oyaizu, N., McCloskey, T. W., Than, S. & Pahwa, S. (2000). CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway. Blood 96, 195-202.
47. ++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection. AIDS 16, 589-596.
48. Vlahakis, S. R., Algeciras-Schimnich, A., Bou, G., Heppelmann, C. J., Villasis-Keever, A., Collman, R. C. & Paya, C. V. (2001). Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. J Clin Invest 107, 207-215.
49. Wei, X., Ghosh, S. K., Taylor, M. E. & 7 other authors (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122.
50. Westendorp, M. O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., Debatin, K. M. & Krammer, P. H. (1995). Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375, 497-500.
51. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. & Lenardo, M. J. (1995). Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377, 348-351.